ImmunoGen closing MA plant: 20 jobs to go, $20m in savings
ImmunoGen says it is shifting drug conjugate manufacturing and quality testing to an outsourcing model and will close its Norwood facility.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs